Kalshi has won approval to list perpetual futures tied to precious metals gold and silver in the U.S., in the latest development as the company seeks to grow its trading offerings beyond prediction markets. 

Originally filed in July, the Commodity Futures Trading Commission — which regulates derivatives contracts — approved the listing of the perpetuals this week.

The new markets for the contracts launched on Thursday on the site.

Kalshi first received approval to list perpetual futures tied to cryptocurrencies in late May, bringing the novel asset class with $90 trillion in annual volume in 2025 onshore to the U.S. for the first time. Since then, the contracts have done $44 billion in notional volume, according to the platform’s website. 

Udesh Jha, chief risk officer at Kalshi Klear, the exchange’s clearing house, said the company moved to have this be their next asset to offer perpetual futures for due to high interest in the commodities. 

“Metals, especially gold and silver, have a story to tell because of inflation,” he said. 

That demand has been reflected in Kalshi’s commodity-related event contracts, which include metals and oil. Volume on the contracts has surpassed $400 million in trading volume in seven months, the company announced on Tuesday, half the time it took its crypto event contracts to reach the same mark.

Perpetual futures, colloquially known as “perps,” are futures-style contracts that have no expiration and do not require an investor to own the underlying asset. Instead, contracts track the price of an asset, with a funding mechanism to keep the contract in-line with the market price.

In addition to perps on precious metals, Kalshi is seeking approval for contracts tied to U.S. equities, industrial metal copper and currencies in August. The green light by the CFTC to list perps tied to precious metals is the first non-crypto related contract that has been approved. 

Following the launch of perps, traditional futures exchanges like CBOE and CME Group saw their stocks tumble on fears that the new futures type could disrupt their existing business models. CME has even sued the CFTC to block the approval of perps in the U.S., under a belief that the agency improperly permitted the contracts. 

But Jha said the early success of Kalshi’s perps offerings is because of its regulated nature.

“It all goes back to the regulated platform,’ he said. “Doing it the right way, a way with proper risk controls… Unregulated platforms, they have always hit a ceiling.”

Disclosure: CNBC and Kalshi have a commercial relationship that includes customer acquisition and a minority investment.

While the new sales teams are doing well, and we feel very good about that continuing in FY ’27, the upsell and renewal teams continue to need focus. We appointed a new leader to run that team, strengthen and expanded the team and realigned the structure around customer size and location. We also implemented a tool to do a better job measuring customer health and kicking off automated and manual workflows based on those results. For example, we can kick off an engagement workflow to a specific cohort of users who have not used the software or used what we know are high-value features.

We started all this in early FY ’26 and saw a nice improvement in renewal rates in Q4 of FY ’26. We expect this more to positively impact net ARR growth as we go into and through FY ’27. We did report a 14% B2B ARR growth during the year, raising our high gross margin platform revenue from 39% of total revenue last year to over 43% this year, which translated into another year of positive results in terms of operating income, net income, EBITDA and cash flow.

In addition to increased spend in sales, we made some additional investments in product development and software engineering, which helped us release 2 new key AI products in addition to increasing development velocity on our core Scite and Article Galaxy products. In addition, we made several internal changes to improve productivity and output, including using AI to help us write and test code. All these improvements drove a large increase in development productivity. In fact, in the third quarter of FY ’25, we were doing about 50 software updates a month. In June of ’26, we did 200, a 4x improvement.

Most importantly, we released 2 AI products that extend the unique capability of Scite and Article Galaxy to be accessible in ChatGPT, Claude or Copilot. This is part of our intent to “be where the researchers are working,” and those products have been well received by our customers. As noted in our press release, we did about $800,000 in AI-related bookings in Q4, and we have built a strong pipeline of interest in those products that we expect we’ll close in FY ’27. I think much of what we did in FY ’27 will set us up nicely to grow the business profitably in FY ’27.

I’d like to pass the call over to Dave to walk you through the fiscal fourth quarter and full year FY ’26 financial results in detail. And then I’ll discuss our goals in FY ’27 and wrap up with some comments and the outlook for the year ahead. Dave?

Dave Kutil: Thank you, Roy, and good afternoon, everyone. I’ll start my comments with a recap of our fourth quarter, followed by a summary of fiscal 2026 results. Total revenue for the fourth quarter of fiscal 2026 was $12.1 million compared to $12.4 million in the fourth quarter of fiscal 2025, as increased platform revenue was more than offset by a decrease in transaction revenue. Our platform subscription revenue was $5.3 million compared to $5.2 million in the prior year quarter. The growth was driven by an increase in B2B platform ARR due to a mix of new logo generation and upsells and cross-sells into our existing customer base, partially offset by a decline in B2C ARR.

We added 29 net new platform deployments in the quarter, bringing total deployments to 1,276 at year-end. We ended the quarter with $22.5 million in annual recurring revenue, up 7.8% year-over-year, which breaks down as approximately $16.2 million in B2B ARR and approximately $6.3 million in normalized ARR associated with sites B2C subscribers. B2B ARR grew $2 million or 14.1% versus the year ago period and included AI-related ARR of $800,000, which grew 125% sequentially from the third quarter of fiscal ’26. Please see today’s press release for how we define and use annual recurring revenue and other non-GAAP terms.

Transaction revenue for the fourth quarter was approximately $6.8 million compared to $7.3 million in the prior year quarter, a decline of approximately 6.7%. That result represents a meaningful improvement from the 11% year-over-year decline we reported in the third quarter and is consistent with the stabilization trend we discussed on last quarter’s call. Our total active customer count for the quarter was 1,323 compared to 1,338 in the same period a year ago. Gross margin for the fourth quarter was 53%, a 200 basis point improvement over the fourth quarter of 2025 and a new quarterly record for the company.

The increase was due to the ongoing revenue mix shift towards our higher-margin platforms business which now represents 43% of our total revenue. The Platform business recorded gross margin of 87.3% compared to an all-time high of 88.5% in the prior year quarter, but still well within our target range of mid-80% gross margin. Gross margin in our Transactions business was 26% compared to 24.1% in our prior year quarter. The increase was primarily attributable to improved margins on our copyright content, reflecting favorable publisher mix and pricing partially offset by lower service fee margins.

Total operating expenses in the quarter were $5.6 million compared to $5.1 million in the prior year quarter, as increased sales and marketing expenses and upfront investments in AI were partially offset by lower general and administrative costs compared to the fourth quarter of fiscal 2025. Other expense for the quarter was $135,000 compared to income of $1.2 million in the prior year quarter. The prior year result was primarily attributable to a favorable adjustments, the final earn-out determination for sites in the fourth quarter of fiscal 2025. As a reminder, as of August 2, we have completed 5 quarters of earn-out payments with 3 additional payments remaining in fiscal 2027.

Net income for the quarter was $666,000 or $0.02 per diluted share compared to $2.4 million or $0.09 per diluted share in the prior year quarter. Adjusted EBITDA for the quarter was $1.4 million compared to $1.6 million for the fourth quarter of last year. Now let me turn to the full year fiscal 2026 results. Total revenue for fiscal 2026 was approximately $48.3 million compared to $49.1 million in fiscal 2025. Platform subscription revenue increased roughly 10% to $20.8 million. Total deployments at year-end were 1,276 and net increase of 105 the deployments from the end of fiscal 2025, and our average sales price increased 4.7% due to the upselling efforts mentioned earlier.

From an ARR perspective, we added approximately $2 million of net B2B ARR during the fiscal year, while normalized B2C ARR declined by approximately $380,000 for the full year. Transaction revenue for fiscal 2026 was $27.5 million compared to $30.1 million in the prior year, a decline of approximately 8.7% as transaction purchases for new customers were more than offset by lower volumes from a small number of large customers and the transactions-related benefits offered within our Platform subscriptions. As I noted earlier, the year-over-year trend improved as we exited the fiscal year. Gross margin for fiscal 2026 was 51.9%, a 260 basis point improvement over fiscal ’25.

The increase is primarily related to our continued revenue shift towards our higher-margin Platform business and it drove a 3.6% increase in gross profit dollars to $25.1 million despite the lower revenue base. Total operating expenses in fiscal 2026 were $21.5 million compared to $21.7 million in the prior year. Lower general and administrative and stock compensation expense were partially offset by higher sales and marketing expenses and product development costs. Other expense for the year was $724,000 and $1.2 million in fiscal 2025. Last year included $1.7 million to reflect the adjustments made to the Scite earn-out finalization.

Net income for fiscal 2026 was $2.8 million or $0.08 per diluted share compared to $1.3 million or $0.04 per diluted share in the prior year. Adjusted EBITDA for the year was $5.8 million compared to $5.3 million in fiscal 2025. Turning to cash flow. Cash flow from operations for the fourth quarter was approximately $1.8 million compared to $2.3 million in the prior year quarter. For the full year, we generated approximately $5.3 million in cash flow from operations compared to approximately $7 million in fiscal 2025.

As we discussed on last quarter’s call, the year-over-year decline primarily reflects the timing of working capital payments rather than a change in the underlying earnings power of the business or the collectibility of our receivables. Turning to our balance sheet. Cash and cash equivalents as of June 30, 2026, were $12.6 million compared to $12.2 million on June 30, 2025. The end of the fiscal year with a higher cash balance than a year ago, even after funding 4 quarters of Scite earn-out payments, consistent with the expectations that we laid out on last year’s fourth quarter call. There were no outstanding borrowings under our revolving line of credit.

And with a growing cash position and no debt, our current balance sheet provides the flexibility to complete the remaining Scite earn-out payments in fiscal 2027, while remaining opportunistic in regard to strategic alternatives. As we look forward to fiscal 2027, we expect continued Platform subscription growth, improving retention and further stabilization in our transactions business. Paired with disciplined expense management, we believe that we are also positioned to deliver another year of adjusted EBITDA growth and strong cash generation. I’ll now turn the call over to Josh to talk about our products. Josh?

Josh Nicholson: Yes. Thanks, Dave, and hello, everyone. I missed the last call as my wife and I welcomed our daughter to the world, really 1 of the best things ever, but I’m happy to be back with you guys today. So today, I want to cover 3 things. What is AI actually doing to our business, what we shipped in response and why we think we are on the right side of the shift. First, the impact of AI on the business, because I know it continues to be the question on everyone’s mind and the question we get a lot.

Our answer is that AI is already reshaping how research gets read, and we can see it directly in our own data. Since we launched the Article Galaxy and Scite MCP connectors in February, AI agents have performed more than 16 million scholarly reads through Scite. Two details in that data matter for how you think about research solutions: One, in June, 4 months after launch; two, calls from AI agents overtook the number of queries in our own Scite assistant interface. Usage didn’t shrink, it moved. Researchers are still asking the same questions.

They’re increasingly asking them inside Claude, ChatGPT and Copilot instead of inside a browser tab and more corporate and academic customers are taking licenses with these tools. Our job is to recognize our differentiators, leverage them and be where the users are and where we are. Scite and Article Galaxy connectors are in the official connector directories of all 3 of these platforms. Copilot, ChatGPT and Claude. Article Galaxy is the only DocDel tool with a connector that integrates directly into LLMs. Scite is 1 of the very few scientific article search connectors, and it adds capability that platforms themselves do not have and other search tools do not have either.

I can tell you whether a claim has been supported or contradicted by later research because we have classified over 1.6 billion citations statements from the full text of the literature. It can also search inside Paywalled full text through our publisher agreement. The second point roughly 43% of what AI agents reach for sits behind a Paywall, that is the unique value that AI and research solutions can deliver together. An agent finds a paper in Scite and about 4 times in 10, it cannot read the full text. Article Galaxy is a compliant rights cleared way to get it. 20 years of publisher relationships and right settlement do not get disrupted by a language model.

It becomes the thing that the language model needs. So the honest answer on AI is this. Legacy per article volume is under pressure, and Dave walked you through the transaction numbers, but the same force that pressures document delivery is creating demand for verified search, verification and rights cleared access, and that demand is landing on our recurring platform business. Second, I want to talk about what we shipped. In fiscal 2026, we put 3 major things into production. The Gateway, MCP access to Scite and Article Galaxy with admin controls, purchasing and ordering and coverage that now extends beyond papers to patent grant clinical trials and drug and device data.

The Meter, metered billing on agent usage, Pro and Teams plans on Scite and pooled usage across an organization. So that the agentic access is something we price for rather than give away. Today, roughly 3/4 of MCP usage comes from paid plans, not free ones. And then self-serve and API console launched in August, so a developer or a pharma data science team or an agent can get started ASAP. Third, why is this working commercially? MCP is behaving as an expansion engine. MCP deals that we closed this year were almost entirely upsells to existing Scite customers, and on average, adding agentic access roughly doubled the contract.

The first article Galaxy MCP deals landed as new logos, a large pipeline Roy continues to grow and the mix is shifting towards larger corporate deals. That shows up in deal size. The average value of new opportunities we create each quarter has nearly doubled over the past 2 years, with the sharpest step-up in the 2 quarters since the MCP launch. It also shows up in retention. Customers who adopt MCP retain at far higher rates than those who do not. The part of the retention fix and the AI strategy are the same work, get customers using agentic access early and they stay. The last piece is the supply side.

We launched a publisher MCP Gateway that makes a publisher’s content discoverable to AI agents while keeping Paywalled full text protected and that gives the publisher a clean read on what AI demand for their catalog looks like. Around 40 publishers are indexed and the first 2 Gateway agreements are signed. Every publisher that joins makes the corporate product more valuable, and every corporate customer makes the Gateway more valuable to publishers. To close, the way research is distributed has shifted twice from print to online and now from online to AI, each time a new layer formed between the content and the reader, and that layer captured the growth. We built the layer this year.

It’s live, it’s metered, and it’s in the base of what we sell. Fiscal 2027 is about scaling it. Back to you, Roy.

Roy Olivier: Thanks, Josh. I think Josh and Dave did a great job framing our results and what we’ve done to lay the groundwork for the future. I want to close covering a few items. First, let’s talk about how I think about FY ’27. It will continue to be a year of change in our industry as we continue to see mass adoption of AI. We have deep vertical market expertise and research, where being 100% correct is required. I think of us as filling the gap between what an LLM can do and what a research-intensive organization expects. What is changing is how researchers start the research journey and what tools they use daily.

What is not changing is that the business is driven by rights management and the costs to do research. What we have always done, we will continue to do, produce tools that researchers can use where they are working in a copyright compliant and cost-efficient way, managing entitlements, company IP, rights, billing and reporting, along with access to almost 160 million journal articles from 1,800 publishers and societies is what is required in enterprise research.

Scite’s access to behind the Paywall information, the unique Scite badge that shows the quality of the article a researcher is looking at and all the supporting business intelligence to help publishers sell AI rights to researchers based on usage data to improve the LLM experience exponentially for both the enterprise and the publisher. When you add that to the fact that we have multiyear customer relationships with over 1,000 enterprises around the world, we believe we’re well positioned to be part of the AI growth story going forward. So what does that mean for FY ’27 results?

While we do not give guidance, I expect to see strong corporate and academic B2B sales in FY ’27 based on our larger and more experienced sales teams and new AI solutions. We have seen and we expect to continue to see improved renewal and upsells based on a larger and more focused team, better tools monitoring leading indicators earlier in the ownership cycle and AI tools that when installed directly translate to higher renewal rates. As noted in our press release and above, we’ve seen a large increase in AI-related product sales and have a strong pipeline going into FY ’27. I do believe it will be a strong year in that regard.

I expect B2C to continue to be a challenging environment as increased competition chases the same individual researcher. I do think our unique value works here as well, but we are typically serving academic researchers in this segment that are very cost sensitive. What we are losing to “try something else,” we are gaining in higher retention, higher monthly payments using MCP with their LLM of choice. Our ASP lifetime value and renewal rates in this segment are going up. The challenge would be to drive any material growth that is acceptable at and acceptable customer acquisition costs. In short, I think this is a flat business for the year.

I do expect to see continued headwinds on transactions or DocDel sales resulting in a low single-digit year-over-year decline as it’s a 5-year — versus its 5-year CAGR of about 1% growth. It’s an important business and will continue to be 1 in the new AI world. Our tools help customers find and acquire what they need in a cost-efficient and copyright compliant way. That’s not going to change. While I don’t have a top line growth number to tell you, I can say that I expect the output of all of this to be improved EBITDA and cash flows in FY ’27. We have almost $13 million in cash, no debt and are generating cash.

While we continue to look at acquisitions that will help us accelerate growth and add unique or strategic capability, we do not have anything lined up in the short term. We do recognize that our stock price is far below where we think it should be and are evaluating all options to increase shareholder value, including stock buybacks or other ways to use the cash to directly impact that. With now — with that, I will now turn the call back over to the operator for Q&A. Operator?

Operator: [Operator Instructions] We will take our first question from Jacob Stephan with Lake Street Capital Markets.

Jacob Stephan: I appreciate you taking the questions and appreciate all the color as well. The AI-related ARR number, that’s the first time you guys have broken that out. How much of that is genuinely incremental customer spend versus kind of like repricing and rebundling of existing subscriptions at renewal? And maybe if as a part B, you can kind of comment on attach rate with FY ’26 renewable?

Roy Olivier: That’s a net ARR growth number of AI-related products that could be an upsell or could be a new sale. I don’t think we did that math and certainly haven’t disclosed it. We will disclose an AI-related revenue number going forward, but I don’t think we’ll split it up across what’s upsell and what’s new. I guess we could, but I’d have to give that some thought. And that’s — I think we said this, but that’s up — that’s compared to near 0 a year ago.

So the point is the MCP, the AI products are starting to generate traction, because that $800,000 number is out of a net ARR growth for the year of, I think, $1.8 million or $1.9 million. Dave, correct me if I’m wrong.

Dave Kutil: Correct. Yes.

Jacob Stephan: Okay. Got it. Maybe if you could comment on pricing a little bit. It seems like a lot of the industry is shifting towards kind of a usage-based model. How are you guys pricing this? Is this more of a per seat basis? Is there some usage component to it? Any color there would be helpful.

Roy Olivier: We do run some pricing models around usage, but typically, the price that’s put in front of the customer is — if it’s not seats, it’s an enterprise, but it has caps for usage and above that, they have to buy additional usage.

Jacob Stephan: Okay. So very similar to kind of how Anthropic and OpenAI are currently working as well.

Roy Olivier: Yes.

Jacob Stephan: Maybe just last 1 for me then. On Scite MCP and Article Galaxy MCP. So if a researcher gets your information or data inside of 1 of those 2, I guess, what keeps them from paying for either Scite or Article Galaxy? Is the MCP kind of a pull-through channel that you guys are using and driving transaction orders? Or is there some kind of intermediary in there?

Roy Olivier: Today, if you want to run MCP, you have to have the corresponding products. So you have to have an AG license to run MCP for AG. You have to have a Scite license to run MCP for Scite. However, we are experimenting with some new models where that won’t necessarily be required. On the AG side, it’s really hard to separate those 2. On the Scite side, it would be easier to separate those 2, and we’re looking at that.

Operator: [Operator Instructions] Our next question will come from Derek Greenberg with Maxim Group.

Derek Greenberg: Just continuing off the last question. I was wondering for the MCP product, you had mentioned that, that’s primarily been an upsell from current customers. I was wondering how usage is tracking on MCP versus the traditional products? If you were to break those out separately, do you see a drop-off in traditional versus the MCP or how you view that dynamic?

Roy Olivier: Do you want to take that one, Josh?

Josh Nicholson: Yes. I discussed this a little bit, and I’ll talk maybe first about the Scite MCP. So if you look at usage in assistant or search compared to MCP, really the users are moving over to MCP. And so assistant usage is declining and MCP is actually really skyrocketing. And so we have over 18 million AI reads. And if you look at the growth of that, which we publish on the Scite, you can see it ticking up even this last week, 1 million reads over that. And so we’re seeing a lot, and this goes to the thesis going to where the users are. And so we’re seeing better retention and more usage through MCP.

For Article Galaxy, we’ve been a bit more conservative on how we roll that out. We are discussing different ways of deploying that. We do see usage across the customer base, and that usage is interesting, but I would say it’s still pretty early. And what we’re tracking there is really looking at the article — purchase to article use. How does that compare platform versus MCP. And in both of those cases, everything is basically plain language, so instead of clicking a button here or there, you’re telling the tool to do this or to search that.

And so I think it really facilitates the use of both core differentiators of the product in where users are starting to live including a lot of our own researchers and developers on the team. More and more of us are daily users of Claude, not just in software development, but really across the org. And we ourselves use MCPs from some of our tools such as our sales CRM and analytics and things like that.

Derek Greenberg: Okay. Got it. And I was wondering if you could talk a little bit more about the Gateway products and maybe the economics there on both the supply and the demand side and just how the traction look on that?

Josh Nicholson: Yes. On that, that’s pretty early, but I think there’s very large demand. I think what publishers are trying to figure out is how does their content exist in this world of AI. And so again, as I mentioned, we’re trying to help bring content into AI just as hosting platforms brought content online. I think where we’ll start to see some of that is that we provide subscription-based access to their subscribers. And so we get value to our product, which we’re charging for, they get value to their subscribers and they get usage data for that. I think this is going to evolve over time.

And I think we ultimately serve a variety of different kind of mechanisms and paths to serve the AI licensing. But I think it’s still early, and there hasn’t been much traction across anyone kind of in the space. But there is demand, and I think we are seeing good interest from some publishers in exploring this with us.

Derek Greenberg: Got it. And then just last 1 for me. I was wondering for the pipeline you mentioned it was growing nicely. I was wondering, last quarter, you provided us over $1 million on the AI products. I was wondering if there’s any more detail you could provide in terms of what that pipeline may look like today?

Roy Olivier: It’s well over that today, but I don’t have an exact number.

Operator: I’m showing no additional questions at this time. I’d like to now turn the call back to Roy Olivier for any additional closing remarks.

Roy Olivier: Thank you, and thanks, everyone, for joining us on our call today. As a reminder, we’ll be participating at the Lake Street Conference tomorrow in New York City. We look forward to speaking with you in November to discuss the first quarter FY ’27 results. Have a great day.

Josh Nicholson: Thank you.

Operator: Thank you. This brings us into today’s meeting. We appreciate your time and participation. You may now disconnect.

Should you buy stock in Research Solutions right now?

Before you buy stock in Research Solutions, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Research Solutions wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $410,024!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,372,815!*

Now, it’s worth noting Stock Advisor’s total average return is 950% — a market-crushing outperformance compared to 211% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of September 10, 2026.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company’s SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

RSSS Q4 2026 Earnings Call Transcript was originally published by The Motley Fool

• REAL Finance’s $ASSET white paper is now listed in ESMA’s MiCA register.
• ESMA listing gives $ASSET a standardised disclosure reference across Europe.
• REAL Finance targets over €3.5 billon in tokenised assets across Europe.

Real Technologies Inc., issuer of the $ASSET token used by the REAL Finance network, has had its crypto-asset white paper listed in the European Securities and Markets Authority’s Interim MiCA Register, giving the project a centralised disclosure reference under the European Union’s crypto rules.

The entry sits in the register for crypto-assets other than asset-referenced tokens and e-money tokens, which falls under Title II of MiCA.

ESMA stresses that white papers appearing in the register have not been reviewed or approved by an EU competent authority, leaving responsibility for their contents with the issuer.

MiCA listing adds a regulatory reference

For REAL Finance, the listing creates a common disclosure point that exchanges, institutions and other counterparties can consult when assessing $ASSET across European Economic Area markets.

The move follows the token’s listing on Kraken, where trading went live on April 30. REAL Finance says $ASSET has also traded on KuCoin and MEXC since April.

“Being listed in ESMA’s Interim MiCA Register gives institutions and exchanges a single, transparent reference for evaluating $ASSET instead of thirty separate national processes. It’s a foundational step for how we want to operate in Europe,” said Ivo Grigorov, CEO of REAL Finance.

The company said the notification addresses a different layer from exchange access, providing standardised regulatory disclosure rather than guaranteeing that any platform will list or continue supporting the token.

REAL Finance pushes deeper into tokenised assets

REAL Finance is positioning the network around the tokenisation of real-world financial assets, an area attracting growing attention from banks, asset managers and regulators.

The company says it aims to tokenise more than €3.5 billion of assets through its European ecosystem and is working with regulated partners, including Austria’s Wiener Privatbank, on custody and structuring.

The MiCA register entry does not amount to regulatory approval of $ASSET. ESMA explicitly states that white papers in the register are not reviewed or endorsed by competent authorities.

Real Technologies also said individual trading venues retain discretion over listing decisions.

That distinction is important as MiCA brings more standardised disclosure to Europe’s crypto market without turning white-paper publication into an official investment endorsement.

The Solana network reached an all-time high in daily token issuance, surpassing the number of new coins issued during the peak of the memecoin cycle in late 2024.

More than 263,000 new Solana Program Library (SPL) tokens were minted on the Solana blockchain on Wednesday, marking a new record high, according to Solscan. Some 40,000 to 50,000 daily tokens were issued on Solana at the peak of the memecoin cycle in December 2024. 

Of the total 40,360 tokens issued through launchpads, memecoin platform Pump.fun accounted for the majority, or 34,184 coins, according to Blockworks’ dashboard.

A launchpad enables creators to easily design, launch and trade memecoins without needing extensive technical skills. They automate the token creation process and provide immediate liquidity and visibility for new tokens.

Pump.fun ranks as the leading Solana-native protocol by daily revenue, with $1.8 million generated in the past 24 hours, according to DefiLlama. Last Friday, Pump.fun’s daily revenue was briefly overtaken by trading app Fomo, which combines cryptocurrency trading with social features resembling a social media feed.

Pump.fun accounted for one-third of Solana’s first-quarter revenue in 2026, or $124 million out of the total $342 million, despite cooling memecoin activity.

Related: Nasdaq invests $100M in Kraken parent at $21B valuation: Report

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.

Ethereum price hovered near $2,468 on Sep. 10 as buyers defended the lower end of a multiweek range, while repeated failures above $2,500 kept the short-term outlook uncertain.

Ethereum price action today

According to data from crypto.news, Ethereum (ETH) price traded around $2,468 at the time of writing after briefly falling to approximately $2,455. The token remained below the psychological $2,500 level, which has repeatedly limited recovery attempts since late August.

The daily chart showed ETH holding inside a narrow range after its rapid August advance from below $1,900. Price has since struggled to extend that rally, with sellers appearing each time it approaches the $2,500 area.

Ethereum’s latest daily candle opened at $2,468.14, reached a high of $2,484.76 and fell as low as $2,455.17. The small trading range showed that neither buyers nor sellers had established firm control during the session.

The broader structure remains stronger than it was before the August breakout. However, ETH is now testing the 8/8 Murray Math resistance at $2,500, making the level an important dividing line between continued consolidation and another upward move.

4-hour indicators show weak buying pressure

On the 4-hour chart, Ethereum traded at $2,469.40, below the Bollinger Bands’ middle line at $2,484.18. The upper band stood at $2,507.87, while the lower band was near $2,460.49.

Price sitting close to the lower band showed that short-term selling pressure remained active. A close below $2,460 could push ETH toward the recent intraday low near $2,445, while a recovery above the middle band would return attention to the $2,500–$2,508 resistance zone.

The Chaikin Money Flow reading was near zero, showing no clear net inflow of capital on the 4-hour timeframe. The neutral reading matched the sideways price structure, with ETH moving between support and resistance without strong follow-through.

The daily Average Directional Index stood at 50.56. An ADX reading above 25 usually indicates a strong trend, but the indicator does not determine its direction. In Ethereum’s case, the elevated reading reflects the strength of the larger move that began in August, even as price consolidates beneath resistance.

Liquidation map places ETH between two liquidity zones

CoinGlass’ 24-hour Ethereum liquidation heatmap showed large concentrations of leveraged positions on both sides of the current price.

The nearest major liquidity cluster below ETH appeared around $2,440. Additional concentrations were visible between approximately $2,400 and $2,430. A break under $2,440 could force leveraged long positions to close and accelerate a move toward those lower bands.

Above the market, the largest nearby liquidation concentrations appeared around $2,490 and between $2,520 and $2,535. Liquidity was also visible near $2,550.

A rebound through $2,490 could therefore trigger short liquidations and pull Ethereum back toward $2,520. However, the number of liquidity bands on both sides of the price raises the risk of sharp moves within the existing range before ETH establishes a clear direction.

The liquidation heatmap also supports the short-term technical boundaries shown by the 4-hour Bollinger Bands. Both charts place Ethereum between support around $2,440–$2,460 and resistance beginning near $2,490.

Analysts identify $2,550 as the breakout level

Crypto trader Daan Crypto Trades said Ethereum had formed a tighter range than Bitcoin while sitting on support near $2,460. According to the analyst, neither bulls nor bears had strong momentum while both assets remained inside their respective ranges.

Daan added that a range break could lead to heavy liquidations among traders positioned on the wrong side. The heatmap supports that risk, with leveraged positions concentrated directly above and below Ethereum’s current market price.

Analyst Ted Pillows identified a wider range between $2,450 and $2,550. He said Ethereum would need a weekly close above $2,550 to begin another upward leg.

A confirmed move above $2,550 would place the next Murray Math target at $2,656.25. Further gains could expose $2,812.50, while the daily chart marks $2,968.75 as a higher resistance level.

The bearish scenario begins with a sustained break below $2,450. The next major daily level sits at $2,343.75, followed by stronger pivot support around $2,187.50. Ted’s weekly chart similarly identifies support near $2,215 if the current range fails.

US macro conditions could decide the range break

Ethereum’s compressed range comes ahead of the Federal Reserve’s Sep. 15–16 policy meeting. US interest-rate expectations remain important for ETH because higher yields can reduce demand for non-yielding risk assets, while a softer policy outlook can support speculative markets.

Until the Fed decision provides more clarity, Ethereum may remain sensitive to changes in Treasury yields, the US dollar and broader risk appetite. Derivatives positioning could amplify the reaction because large liquidation clusters sit close to both sides of the current price.

Advertisement

The immediate technical decision remains clear. Holding $2,440–$2,460 would preserve the range and allow another test of $2,500. Ethereum needs a weekly close above $2,550 to confirm stronger upside momentum, while a loss of $2,440 would shift attention toward $2,344 and $2,215.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

Advertisement